Chemoinformaics analysis of 6-Chromanol, 2,8-dimethyl-2-(4,8,12-trimethyltridecyl)-
| Molecular Weight | 402.663 | nRot | 12 |
| Heavy Atom Molecular Weight | 356.295 | nRig | 21 |
| Exact Molecular Weight | 402.35 | nRing | 2 |
| Solubility: LogS | -3.288 | nHRing | 1 |
| Solubility: LogP | 1.448 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 75 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 29 | No. of Aromatic Carbocycles | 1 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 46 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 27 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 6 |
| nHA | 2 | APOL | 77.3665 |
| nHD | 1 | BPOL | 47.8835 |
| QED | 0.903 |
| Synth | 4.629 |
| Natural Product Likeliness | 1.545 |
| NR-PPAR-gamma | 0.639 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.891 |
| Pgp-sub | 0.01 |
| HIA | 0.03 |
| CACO-2 | -5.095 |
| MDCK | 0.0000271 |
| BBB | 0.364 |
| PPB | 0.86304 |
| VDSS | 1.017 |
| FU | 0.159353 |
| CYP1A2-inh | 0.033 |
| CYP1A2-sub | 0.793 |
| CYP2c19-inh | 0.445 |
| CYP2c19-sub | 0.892 |
| CYP2c9-inh | 0.278 |
| CYP2c9-sub | 0.607 |
| CYP2d6-inh | 0.034 |
| CYP2d6-sub | 0.6 |
| CYP3a4-inh | 0.543 |
| CYP3a4-sub | 0.92 |
| CL | 13.834 |
| T12 | 0.725 |
| hERG | 0.061 |
| Ames | 0.072 |
| ROA | 0.27 |
| SkinSen | 0.184 |
| Carcinogencity | 0.586 |
| EI | 0.013 |
| Respiratory | 0.959 |
| NR-Aromatase | 0.792 |
| Antiviral | No |
| Prediction | 0.674058 |